Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Retrophin Inc (NASDAQ:RTRX)

24.94
Delayed Data
As of 3:59pm ET
 +0.94 / +3.92%
Today’s Change
15.55
Today|||52-Week Range
25.44
+31.75%
Year-to-Date
No recent news for Retrophin Inc.

Today’s Trading

Previous close24.00
Today’s open24.11
Day’s range24.04 - 24.99
Volume278,397
Average volume (3 months)305,789
Market cap$921.2M
Dividend yield--
Data as of 3:59pm ET, 10/18/2017

Growth & Valuation

Earnings growth (last year)-140.69%
Earnings growth (this year)+11.63%
Earnings growth (next 5 years)+137.00%
Revenue growth (last year)+33.74%
P/E ratioNM
Price/Sales5.43
Price/Book2.96

Competitors

 Today’s
change
Today’s
% change
FPRXFive Prime Therapeut...-0.60-1.29%
EDITEditas Medicine Inc+0.13+0.56%
EPZMEpizyme Inc-0.20-1.14%
NDRMNeuroderm Ltd-38.85-100.00%
Data as of 4:00pm ET, 10/18/2017

Financials

Next reporting dateNovember 20, 2017
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$133.6M
Annual profit (last year)-$47.9M
Net profit margin-35.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen J. Aselage
Chief Operating Officer
Neil McFarlane
Corporate headquarters
San Diego, California

Forecasts